Pharma BD Deal Intelligence
Flagship Pioneering merged two of its AI-based drug discovery companies: Valo Health and Montai Therapeutics combined into a single company retaining the Valo Health name, led by Valo CEO and Flagship CEO-Partner Brian Alexander. The merger joins Valo's AI-enabled human causal biology and predictive chemistry with Montai's clinical-stage immunology and inflammation pipeline, led by MTAI-1025 and an oral STAT6 inhibitor for atopic dermatitis and other type 2 inflammatory diseases. Financial terms were not disclosed.
← Browse all deals · How we score deals
More: 2026 deals